Department of Physical Therapy, Sahmyook University, Hwarangro 815, Nowon-gu, Seoul 139-742, Republic of Korea.
Department of Pathology, CHA Ilsan Medical Center, 1205 Jungang-ro, Ilsandong-gu, Goyang-si, Gyeonggi-do, Republic of Korea.
Anal Cell Pathol (Amst). 2022 Feb 25;2022:3686863. doi: 10.1155/2022/3686863. eCollection 2022.
Post-burn hypertrophic scars commonly occur after burns. Studies that compare dermal substitutes with other treatment methods are insufficient. The purpose was to analyze the histopathological differences in hypertrophic burn scars after Matriderm®+split-thickness skin graft (STSG) and compare with AlloDerm®+STSG, STSG, full-thickness skin graft (FTSG), and normal skin.
Samples of unburned, normal skin and deep 2 or 3 degree burns were obtained from patients who experienced a burn injury in the past to at least 6 months before biopsy, which was performed between 2011 and 2012. All subjects received >6 months of treatment before the biopsy. Intervention groups were normal (63), STSG (28), FTSG (6), Matriderm® (11), and AlloDerm® (18). Immunohistochemical analyses of elastin, collagen I, collagen III, cluster of differentiation 31 (CD31), smooth muscle actin (-SMA), and laminin from scar and control tissues were performed and compared.
-SMA vascular quantity and vessel width, stromal CD31, and basement membrane laminin expression were not significantly different between normal and intervention groups. Matriderm® group showed no significant difference in elastin, collagen III, stromal CD31 and -SMA, CD31 vessel width, stromal -SMA, vessel quantity and width, and laminin length compared to the normal group, meaning they were not significantly different from the normal skin traits.
Dermal substitutes may be an optimal alternative to address the cosmetic and functional limitations posed by other treatment methods.
烧伤后常发生增生性瘢痕。比较真皮替代物与其他治疗方法的研究还不够。目的是分析 Matriderm®+ 断层皮片(STSG)和 AlloDerm®+STSG、STSG、全厚皮片(FTSG)与正常皮肤治疗后增生性烧伤瘢痕的组织病理学差异,并进行比较。
从过去至少 6 个月前发生烧伤、至少接受 6 个月治疗后才进行活检的患者中获得未烧伤的正常皮肤和深 2 或 3 度烧伤样本,活检时间为 2011 年至 2012 年。干预组包括正常皮肤(63 例)、STSG(28 例)、FTSG(6 例)、Matriderm®(11 例)和 AlloDerm®(18 例)。对瘢痕和对照组织中的弹性蛋白、I 型胶原、III 型胶原、CD31 簇分化(CD31)、平滑肌肌动蛋白(-SMA)和层粘连蛋白进行免疫组织化学分析,并进行比较。
正常组与干预组之间,-SMA 血管数量和血管宽度、基质 CD31 和基底膜层粘连蛋白表达均无显著差异。Matriderm®组的弹性蛋白、III 型胶原、基质 CD31 和 -SMA、CD31 血管宽度、基质 -SMA、血管数量和宽度以及层粘连蛋白长度与正常组无显著差异,与正常皮肤特征无显著差异。
真皮替代物可能是一种治疗增生性瘢痕的替代方法,它可以解决其他治疗方法带来的美容和功能限制。